UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2024 Earnings Call Transcript March 10, 2025
Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the UroGen Pharma Fourth Quarter and Full Year 2024 Earnings Call. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Vincent Perrone, Head of Investor Relations. Please go ahead.
Vincent Perrone: Thank you, operator. Good morning, everyone, and...
